Bioavailability and foam cells permeability enhancement of Salvianolic acid B pellets based on drug-phospholipids complex technique.
暂无分享,去创建一个
W. Zhang | Yan Cui | Jian-Ping Liu | Jin Li | Pan Liu | Wen-li Zhang | Jikun Yang | Yong-Qing Fan | Shuling Kan
[1] G. Schneider,et al. Structural properties of so-called NSAID-phospholipid-complexes. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[2] Yong Zhang,et al. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel , 2010, Comput. Methods Programs Biomed..
[3] M. Semalty,et al. Supramolecular phospholipids-polyphenolics interactions: the PHYTOSOME strategy to improve the bioavailability of phytochemicals. , 2010, Fitoterapia.
[4] Weifeng Zhu,et al. Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex. , 2010, International journal of pharmaceutics.
[5] X. Hao,et al. Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex technique. , 2010, International journal of pharmaceutics.
[6] Z. Zuo,et al. Effect of sodium caprate on the oral absorptions of danshensu and salvianolic acid B. , 2009, International journal of pharmaceutics.
[7] J. Ni,et al. TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation , 2009, Proceedings of the National Academy of Sciences.
[8] D. Guo,et al. Cardioprotection and matrix metalloproteinase-9 regulation of salvianolic acids on myocardial infarction in rats. , 2009, Planta Medica.
[9] Xing Tang,et al. Formulation of an intravenous emulsion loaded with a clarithromycin-phospholipid complex and its pharmacokinetics in rats. , 2009, International journal of pharmaceutics.
[10] E. Atef,et al. Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS). , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[11] T. Hibi,et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. , 2008, Pharmacology & therapeutics.
[12] Siling Wang,et al. Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization. , 2007, International journal of pharmaceutics.
[13] K. Mäder,et al. Preparation and characterization of a self-emulsifying pellet formulation. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[14] P. Mukherjee,et al. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. , 2007, International journal of pharmaceutics.
[15] Ming-Shi Shiao,et al. Bioavailability of salvianolic acid B in conscious and freely moving rats. , 2006, International journal of pharmaceutics.
[16] Y. Kawashima,et al. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[17] Q. Ping,et al. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. , 2006, International journal of pharmaceutics.
[18] E. Franceschinis,et al. Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption. , 2005, International journal of pharmaceutics.
[19] V. Sinha,et al. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization. , 2005, Current drug delivery.
[20] Peter Kleinebudde,et al. The Crystallite-Gel-Model for Microcrystalline Cellulose in Wet-Granulation, Extrusion, and Spheronization , 1997, Pharmaceutical Research.
[21] W. Garvey,et al. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. , 2004, Blood cells, molecules & diseases.
[22] Peng Yang,et al. Intercellular adhesion molecule-1 and vascular endothelial growth factor expression kinetics in macrophage-derived foam cells. , 2003, Life sciences.
[23] M. Khan,et al. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. , 2002, International journal of pharmaceutics.
[24] Jian-feng Wu,et al. [Study on the preparation of baicalin complex with phospholipid]. , 2001, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[25] Y. Siow,et al. Magnesium tanshinoate B (MTB) inhibits low density lipoprotein oxidation. , 2001, Life sciences.
[26] T. Kita,et al. Molecular Cloning of a Novel Scavenger Receptor for Oxidized Low Density Lipoprotein, SR-PSOX, on Macrophages* , 2000, The Journal of Biological Chemistry.
[27] S. Benita,et al. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[28] R Panchagnula,et al. Biopharmaceutics and pharmacokinetics in drug research. , 2000, International journal of pharmaceutics.
[29] E. Lasonder,et al. An NMR and DSC study of the interaction of phospholipid vesicles with some anti-inflammatory agents , 1990 .
[30] W. D. Weringa,et al. The interactions of phospholipid vesicles with some anti-inflammatory agents , 1988 .